Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.29%235.22M | 16.55%952.78M | 4.03%230.5M | 9.08%225.52M | 21.47%243.05M | 34.19%253.71M | -13.80%817.48M | 12.22%221.57M | 2.32%206.75M | -18.54%200.09M |
| Cost of revenue | 21.24%706.37M | -18.98%582.62M | ||||||||
| Gross profit | 4.92%246.41M | 2.46%234.85M | ||||||||
| Operating expense | -8.33%220.09M | 1.95%200.13M | 3.96%217.34M | 10.37%212.22M | 21.67%227.62M | 35.69%240.1M | 12.38%196.31M | 140.08%209.05M | 3.41%192.28M | -17.32%187.07M |
| Selling and administrative expenses | ---- | 1.95%200.13M | ---- | ---- | ---- | ---- | 12.38%196.31M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 1.95%200.13M | ---- | ---- | ---- | ---- | 12.38%196.31M | ---- | ---- | ---- |
| Other operating expenses | -8.24%223.34M | 16.38%906.51M | 2.85%220.41M | 9.84%213.72M | 21.32%228.98M | 34.23%243.4M | --778.94M | --214.3M | 3.27%194.58M | -17.43%188.73M |
| Total other operating income | -1.73%3.24M | -32.08%9.23M | -41.49%3.07M | -34.48%1.5M | -18.32%1.36M | -24.77%3.3M | --13.59M | --5.25M | -7.20%2.29M | -28.18%1.66M |
| Operating profit | 11.15%15.13M | 20.04%46.27M | 5.10%13.16M | -8.09%13.3M | 18.55%15.43M | 12.30%13.61M | -29.30%38.55M | 12,025.71%12.52M | -10.27%14.47M | -32.75%13.02M |
| Net non-operating interest income (expenses) | -12.39%-2.7M | -16.96%-9.4M | 20.27%-2.32M | -17.79%-2.31M | -50.10%-2.36M | -51.54%-2.41M | -2.88%-8.03M | -50.65%-2.92M | -5.20%-1.96M | 22.90%-1.57M |
| Non-operating interest expense | 12.39%2.7M | 16.96%9.4M | -20.27%2.32M | 17.79%2.31M | 50.10%2.36M | 51.54%2.41M | 2.88%8.03M | 50.65%2.92M | 5.20%1.96M | -22.90%1.57M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -40.94%388K | -35.28%1.66M | -81.27%153K | -50.98%450K | -2.23%394K | 56.43%657K | -1.50%2.56M | 215.44%817K | 8.00%918K | -36.83%403K |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -32.05%9.23M | 4.95%13.58M | ||||||||
| Income before tax | 8.02%12.82M | 2.37%47.76M | 5.43%10.99M | -14.80%11.44M | 13.67%13.47M | 8.31%11.86M | -25.05%46.66M | -6.61%10.42M | -11.16%13.43M | -34.02%11.85M |
| Income tax | -12.10%3.12M | -2.57%12.61M | -34.38%2.25M | 0.84%3.6M | 10.87%3.21M | 16.30%3.55M | -14.27%12.95M | 63.14%3.42M | -2.88%3.57M | -38.25%2.9M |
| Net income | 16.62%9.69M | 4.27%35.15M | 24.88%8.75M | -20.47%7.84M | 14.58%10.26M | 5.22%8.31M | -28.51%33.71M | -22.75%7M | -13.81%9.86M | -32.52%8.95M |
| Net income continuous operations | 16.62%9.69M | 4.27%35.15M | 24.88%8.75M | -20.47%7.84M | 14.58%10.26M | 5.22%8.31M | -28.51%33.71M | -22.75%7M | -13.81%9.86M | -32.52%8.95M |
| Noncontrolling interests | -6.45%986K | 43.89%4.05M | 99.14%693K | 3.38%857K | 53.55%1.45M | 51.44%1.05M | -45.27%2.82M | -73.85%348K | 25.42%829K | -48.13%943K |
| Net income attributable to the company | 19.97%8.71M | 0.66%31.1M | 20.99%8.05M | -22.66%6.98M | 9.99%8.81M | 0.75%7.26M | -26.45%30.9M | -13.95%6.66M | -16.22%9.03M | -30.04%8.01M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 19.97%8.71M | 0.66%31.1M | 20.99%8.05M | -22.66%6.98M | 9.99%8.81M | 0.75%7.26M | -26.45%30.9M | -13.95%6.66M | -16.22%9.03M | -30.04%8.01M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 20.00%0.0156 | 0.72%0.0557 | 21.01%0.0144 | -22.84%0.0125 | 10.49%0.0158 | 0.78%0.013 | -26.46%0.0553 | -13.77%0.0119 | -16.06%0.0162 | -30.24%0.0143 |
| Diluted earnings per share | 20.00%0.0156 | 0.72%0.0557 | 21.01%0.0144 | -22.84%0.0125 | 10.49%0.0158 | 0.78%0.013 | -26.46%0.0553 | -13.77%0.0119 | -16.06%0.0162 | -30.24%0.0143 |
| Dividend per share | -33.33%0.02 | 83.33%0.055 | 0.01 | 50.00%0.015 | 0 | 50.00%0.03 | -25.00%0.03 | 0 | 0.00%0.01 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.